MedTrace Logo

Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countries

NCT07572747 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 6740

Last updated 2026-05-11

No results posted yet for this study

Summary

Determine the long-term efficacy of clopidogrel compared with aspirin in reducing heart or brain attacks in patients with stable heart disease

Conditions

  • Chronic Coronary Syndrome

Interventions

DRUG

Aspirin

Aspirin

DRUG

Clopidgrel 75 mg daily

Clopidogrel

Sponsors & Collaborators

  • Khalid F Alhabib

    lead OTHER

Principal Investigators

  • Khalid Alhabib · King Saud University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-04-01
Primary Completion
2032-04-01
Completion
2032-04-01
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07572747 on ClinicalTrials.gov